What is RYET's health score?

Ruanyun Edai Technology Inc. (RYET) has a TradeApes health score of 41 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is RYET's estimated fair value?

Based on our 5-year discounted cash flow model, Ruanyun Edai Technology Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is RYET undervalued or overvalued?

Our model currently rates RYET as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for RYET... Refresh in a moment for the full analysis.

Ruanyun Edai Technology Inc. (RYET)

Technology Inconclusive inconclusive weak

$0.87

Updated: 2026-06-05

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

38 Weak

Relative Value

50 Mixed

Capital Allocation

50 Mixed

Risk

50 Mixed

Key Findings

+ High ROIC — above 20%, excellent return on invested capital

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.